These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7081082)

  • 21. Amiodarone-induced polymorphous ventricular tachycardia.
    Sclarovsky S; Lewin RF; Kracoff O; Strasberg B; Arditti A; Agmon J
    Am Heart J; 1983 Jan; 105(1):6-12. PubMed ID: 6849241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial inducible torsade de pointes with normal QT interval.
    Strasberg B; Welch W; Palileo E; Swiryn S; Bauernfeind R; Rosen KM
    Eur Heart J; 1983 Jun; 4(6):383-90. PubMed ID: 6617684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
    Keren A; Tzivoni D; Gavish D; Levi J; Gottlieb S; Benhorin J; Stern S
    Circulation; 1981 Dec; 64(6):1167-74. PubMed ID: 7296791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
    Kim SY; Benowitz NL
    Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Torsade de pointes syndromes. Variations and limits].
    Coumel P; Lucet V
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):205-14. PubMed ID: 3740773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations.
    Jenzer HR; Hagemeijer F
    Eur J Cardiol; 1976 Dec; 4(4):447-51. PubMed ID: 63370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsade de pointe atypical ventricular tachycardia complicating subarachnoid hemorrhage.
    Carruth JE; Silverman ME
    Chest; 1980 Dec; 78(6):886-8. PubMed ID: 7449473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol.
    Kemper AJ; Dunlap R; Pietro DA
    JAMA; 1983 Jun; 249(21):2931-4. PubMed ID: 6842807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphous ventricular tachycardia associated with acute myocardial infarction.
    Wolfe CL; Nibley C; Bhandari A; Chatterjee K; Scheinman M
    Circulation; 1991 Oct; 84(4):1543-51. PubMed ID: 1914096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsade de pointes and other pause-induced ventricular tachycardias: the short-long-short sequence and early afterdepolarizations.
    Cranefield PF; Aronson RS
    Pacing Clin Electrophysiol; 1988 Jun; 11(6 Pt 1):670-8. PubMed ID: 2456546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.
    Kay GN; Plumb VJ; Arciniegas JG; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1983 Nov; 2(5):806-17. PubMed ID: 6630761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    Commerford PJ; Beck W
    S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities.
    Horowitz LN; Greenspan AM; Spielman SR; Josephson ME
    Circulation; 1981 May; 63(5):1120-8. PubMed ID: 7471373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular pacing in atypical ventricular tachycardia.
    Keren A; Tzivoni D; Golhman JM; Corcos P; Benhorin J; Stern S
    J Electrocardiol; 1981; 14(2):201-5. PubMed ID: 7276791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torsade de pointes tachycardias induced by overdosage of zimeldine.
    Liljeqvist JA; Edvardsson N
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):666-70. PubMed ID: 2478783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prinzmetal's angina with Torsade de Pointes ventricular tachycardia.
    Sawaya JI; Rubeiz GA
    Acta Cardiol; 1980; 35(1):47-54. PubMed ID: 6967668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent torsade de pointes type ventricular tachycardia in intracranial hemorrhage.
    Sen S; Stober T; Burger L; Anstätt T; Rettig G
    Intensive Care Med; 1984; 10(5):263-4. PubMed ID: 6491039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphous ventricular tachycardia associated with a marked prolongation of the Q-T interval induced by amiodarone.
    Bhandari AK; Quock C; Sung RJ
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 1):341-5. PubMed ID: 6204284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.